The IBMS Cytology Advisory Panel made the decision to totally review and relaunch the cytology Specialist Portfolios to better reflect the more focused services now provided by laboratories
The changes also reflect the increasing role molecular based techniques are playing across pathology as a whole and increasingly so within cytology.
The outcome of the review is two new cytology portfolios in cervical and diagnostic cytology that have evolved from the previous combined version. Additional elements have been added to both fields to reflect the expansion of expected knowledge now required. This can be seen most noticeably within the diagnostic cytology version.